Description
Product details
VELAXFINE XR 37.5 Venlafaxine (37.5mg) Introduction: VELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients. Key Features and Benefits: Antidepressant Action: VELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression. Anxiety Relief: Venlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating. Extended-Release Formulation: The extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness. Improved Quality of Life: By effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally. Well-Tolerated and Safe: VELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders. Dosage and Administration: Initial Dosage for Depression and Anxiety: The recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability. Maintenance Dosage: The usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days. Administration Instructions: VELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort. Continued Monitoring: Regular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order NOW https://www.sterisonline.com/product/velaxfine-xr-37-5-134393